Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences
March 29, 2022 10:56 ET
|
Cytovia Therapeutics
AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...
Insights on the Cell and Gene Therapy World Market to 2031 - by Product Segments, Method and Geographical Region
March 24, 2022 07:03 ET
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy World Market and Market Potential" report has been added to ResearchAndMarkets.com's offering. The report examines...
Global Gene Editing Beyond CRISPR Market (2022 to 2035) - Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies
March 22, 2022 06:13 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies:...
Global Gene Editing Partnering Deals Collection 2010-2022 | Access to 400+ Deals Entered Into by the World's Leading Healthcare Companies
March 18, 2022 07:18 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Editing Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Gene Editing...
Insights on the Cell and Gene Therapy Global Market to 2026 - by Therapy Type, Product, Application and Region
February 23, 2022 05:13 ET
|
Research and Markets
Dublin, Feb. 23, 2022 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for cell and gene...
Global CRISPR Market & Competition Landscape 2021-2028 Featuring Profiles of Integrated DNA Technologies, Intellia Therapeutics, Horizon Discovery Group, and Precision Biosciences Among Others
February 04, 2022 05:38 ET
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is anticipated to display growth...
Outlook on the Oligonucleotide Synthesis Global Market - Featuring Abbott Diagnostics, Amyris and Bayer Among Others
February 03, 2022 04:38 ET
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
Global CRISPR Gene Editing Market Report 2021-2031: Opportunities in Expanding Gene and Cell Therapy Area & CRISPR Gene Editing Scope in Agriculture
January 14, 2022 05:33 ET
|
Research and Markets
Dublin, Jan. 14, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Gene Editing Market - A Global and Regional Analysis: Focus on Product, Application, End User, and Country-Wise Analysis - Analysis and...
Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners
December 14, 2021 03:00 ET
|
MEIOGENIX
Paris, France, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced...
Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9
November 10, 2021 07:30 ET
|
Exavir Therapeutics
Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...